These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12169935)

  • 21. Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance.
    Gennari R; Alexander JW; Gianotti L; Eaves-Pyles T; Hartmann S
    Ann Surg; 1994 Jul; 220(1):68-76. PubMed ID: 8024361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in survival with peptidyl membrane interactive molecule D4B treatment after burn wound infection.
    Gamelli RL; He LK; Liu H; Ricken JD
    Arch Surg; 1998 Jul; 133(7):715-20. PubMed ID: 9687998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
    Güenechea G; Bueren JA; Maganto G; Tuduri P; Guerrero A; Pivel JP; Real A
    Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia.
    de Haan G; Loeffler M; Nijhof W
    Exp Hematol; 1992 Jun; 20(5):600-4. PubMed ID: 1375161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of burn injury on granulocyte and macrophage production.
    Gamelli RL; Hebert JC; Foster RS
    J Trauma; 1985 Jul; 25(7):615-9. PubMed ID: 4009767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3.
    Cairo MS; Mauss D; Plunkett JM; Gillis S; van de Ven C
    Pediatr Res; 1991 May; 29(5):504-9. PubMed ID: 1896256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of synergy between granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in colony formation from human marrow cells in vitro.
    Hara H; Namiki M
    Exp Hematol; 1989 Aug; 17(7):816-21. PubMed ID: 2473914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human granulocyte-colony stimulating factor and recombinant human macrophage-colony stimulating factor synergize in vivo to enhance proliferation of granulocyte-macrophage, erythroid, and multipotential progenitor cells in mice.
    Broxmeyer HE; Williams DE; Cooper S; Hangoc G; Ralph P
    J Cell Biochem; 1988 Oct; 38(2):127-36. PubMed ID: 2464604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose dependency of granulocyte-macrophage colony stimulating factor for improving survival following burn wound infection.
    O'Reilly M; Silver GM; Gamelli RL; Davis JH; Hebert JC
    J Trauma; 1994 Apr; 36(4):486-90. PubMed ID: 8158707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte colony-stimulating factor enhances killing of translocated bacteria but does not affect barrier function in a burn mouse model.
    Eaves-Pyles T; Alexander JW
    J Trauma; 1996 Dec; 41(6):1013-7. PubMed ID: 8970555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells.
    Lagneaux L; Delforge A; Snoeck R; Stryckmans P; Bron D
    Exp Hematol; 1994 Jan; 22(1):26-30. PubMed ID: 7506672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.
    Lieschke GJ; Grail D; Hodgson G; Metcalf D; Stanley E; Cheers C; Fowler KJ; Basu S; Zhan YF; Dunn AR
    Blood; 1994 Sep; 84(6):1737-46. PubMed ID: 7521686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocyte colony-stimulating factor and an RARalpha specific agonist, VTP195183, synergize to enhance the mobilization of hematopoietic progenitor cells.
    Herbert KE; Walkley CR; Winkler IG; Hendy J; Olsen GH; Yuan YD; Chandraratna RA; Prince HM; Lévesque JP; Purton LE
    Transplantation; 2007 Feb; 83(4):375-84. PubMed ID: 17318068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of recombinant human macrophage-colony stimulating factor on marrow, splenic, and peripheral hematopoietic progenitor cells in mice.
    Yamauchi T; Yada K; Umemura A; Asakura E; Hanamura T; Tanabe T
    J Leukoc Biol; 1996 Feb; 59(2):296-301. PubMed ID: 8604003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantation.
    Haas R; Gericke G; Witt B; Cayeux S; Hunstein W
    Exp Hematol; 1993 Jan; 21(1):109-13. PubMed ID: 7678083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of burn with and without Escherichia coli infection in rats on intestinal vs. splenic T-cell responses.
    Ravindranath T; Al-Ghoul W; Namak S; Fazal N; Durazo-Arvizu R; Choudhry M; Sayeed MM
    Crit Care Med; 2001 Dec; 29(12):2245-50. PubMed ID: 11801815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.
    Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarction.
    Delgaudine M; Gothot A; Beguin Y
    Cytotherapy; 2010 Nov; 12(7):909-18. PubMed ID: 20230223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.